Drug Type Small molecule drug |
Synonyms Biapenem (JAN/USAN/INN), CL 186815, CL-186815 + [11] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (02 Oct 2001), |
Regulation- |
Molecular FormulaC15H18N4O4S |
InChIKeyMRMBZHPJVKCOMA-YJFSRANCSA-N |
CAS Registry120410-24-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | China | 04 May 2008 | |
Cystitis | Japan | 02 Oct 2001 | |
Hemorrhagic Septicemia | Japan | 02 Oct 2001 | |
Lung Abscess | Japan | 02 Oct 2001 | |
Peritonitis | Japan | 02 Oct 2001 | |
Pneumonia | Japan | 02 Oct 2001 | |
Pyelonephritis | Japan | 02 Oct 2001 | |
Secondary infection | Japan | 02 Oct 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Complicated urinary tract infection | Phase 2 | China | 19 Jun 2009 | |
Respiratory Tract Infections | Phase 2 | China | - |